Search results

ANSTO has unique facilities, capabilities and expertise to investigate materials in extreme environments for applications in energy systems, the defence industry and emerging space sector.

ANSTO will be participating in a new Industrial Transformation Training Centre established and funded by the Australia Research Council to advance the use of bioactive ingredients in Australia.

ANSTO’s National Deuteration Facility has been providing high-quality deuterated lipids used in the construction of cell membrane models to support research that improves our understanding of how the virus interacts with elements of the cell membrane, a relatively new area of investigation.

ABC has reported space research on plants being sent to the moon at the Centre for Accelerator Science.

In early February, ANSTO was honoured to host the International Atomic Energy Agency (IAEA) National Liaison Officers Meeting and Sub Regional Approach to the Pacific Islands (SAPI) Programme, which focused on the development and delivery of the IAEA Technical Cooperation Programme in the Pacific.

The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.

An unusual and very exciting form of carbon - that can be created by drawing on paper - looks to hold the key to real-time, high throughput DNA sequencing, a technique that would revolutionise medical research and testing.

The NSW Government will invest $12.5 million to support the expansion of the Innovation Precinct at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO).

In mid-February ANSTO attended a meeting at the International Atomic Energy Agency (IAEA) to discuss and produce recommendations for the development of a new Coordinated Research Project (CRP) on Seafood Origin and Authenticity using Nuclear and Related Technologies to progress the IAEA flagship initiative Atoms4Food.

A groundbreaking international study has provided new insights into global fossil methane emissions, using innovative multi-isotopic atmospheric measurements.  

The new targeted treatment for aggressive prostate cancer, which include lutetium produced at ANSTO, has shown to produce more potent and durable responses in men and with fewer side-effects.